Last reviewed · How we verify
NCT03465371: CSCPII
CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care
NA trial testing CSC OnDemand Training Intervention in Psychosis in 349 participants. Completed in 31 January 2022.
31 January 2022
Quick facts
| Lead sponsor | Center for Social Innovation, Massachusetts |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 349 |
| Start date | 1 October 2018 |
| Primary completion | 31 January 2022 |
| Estimated completion | 31 January 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- CSC OnDemand Training Intervention
- InPerson Intervention
- Virtual InPerson Intervention
Conditions studied
- Psychosis — all drugs for Psychosis →
Sponsor
Center for Social Innovation, Massachusetts
Who can join
18 and older, any sex, with Psychosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In response to the growing need for training on interventions to address first episode psychosis, the Center for Social Innovation (C4) partnered with experts in Coordinated Specialty Care (CSC) to develop and test CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care. The product builds on the findings of the Recovery After an Initial Schizophrenia Episode (RAISE) studies, funded by the National Institute of Mental Health (NIMH). RAISE examined team-based models of care for people early in the course of schizophrenia. Through a Fast Track Small Business Innovation Research (SBIR) grant, investigators will prototype, test, refine, and evaluate the impact of CSC OnDemand.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03465371
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Psychosis
Currently open trials in the same condition.
- NCT07213492 — Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder · NA · recruiting
- NCT07056894 — Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis · NA · recruiting
- NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis · NA · recruiting
- NCT07196462 — Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia · NA · recruiting
- NCT07364825 — Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care · NA · recruiting
Other Center for Social Innovation, Massachusetts trials
Trials by the same sponsor.
- NCT06266572 — Overcoming Stigma and Improving Outcomes for SUDs Through Education, Engagement, and Empowerment · Phase 1 · completed
- NCT03390491 — OnTrack>An Online Role-Playing Game for Young People With First Episode Psychosis · NA · completed
- NCT03053557 — Testing a New Device to Advance the Use of Social Skills Training With Mental Health Consumers and Clinicians · NA · completed
- NCT02707367 — Recovery Roadmap Phase II Small Business Innovation Research Grant · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03465371 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Center for Social Innovation, Massachusetts
- Last refreshed: 2 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03465371.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing